Featured News
More News
JDRF announces new center of excellence to be co-directed by Dr. Seung Kim, Director of the SDRC
JDRF launched the JDRF Northern California Center of Excellence with the goal of accelerating breakthrough research to develop novel therapeutic strategies to cure type 1 diabetes.
SDRC member, Dr. Irv Weissman awarded Albany Prize
Weissman and Johns Hopkins’ Bert Vogelstein will share the 2019 Albany Medical Center Prize in Medicine and Biomedical Research for discoveries in stem cell and cancer biology.
Stanford team stimulates neurons to induce particular perceptions in mice's minds
Stanford scientists, using only direct brain stimulation, reproduced both the brain dynamics and the behavioral response of mice taught to discriminate between two different images.
What happens when a person with prediabetes get a viral infection? New study provides in-depth look
As the number of individuals with Type 2 diabetes in the United States continues to climb, researchers at Stanford Medicine are investigating the connection between a condition known as prediabetes -- an early indicator of diabetes that involves higher-than-normal blood sugar levels -- and immune and microbiome health.
SDRC funded study led by Dr. Joe Wu shows that e-cigarette flavorings have damaging effects
E-cigarette flavorings damage human blood vessel cells grown in the lab even in the absence of nicotine, Stanford researchers and their colleagues found. Cinnamon and menthol flavors were particularly harmful.
A decade-long study finds that roughly 1 in 10 people carry genetic variants that may blunt the blood sugar-lowering effects of widely used diabetes medications — raising new questions about precision medicine in diabetes care. Read more...